BraveCX, an artificial intelligence (AI)-enabled software, reportedly has an area under the curve (AUC) of 98 percent for detecting pneumothorax on chest X-rays.
The Food and Drug Administration (FDA) has granted 510(k) clearance for BraveCX, an emerging triage and notification software for adult chest X-rays, that may facilitate timely diagnosis for urgent cases in an emergency room setting.
BraveCX provides specificity rates ranging between 95 to 97 percent, and areas under the curve (AUC) of 96 percent for pleural effusion and 98 percent for pneumothorax, according to Bering, the developer of BraveCX.
Bering pointed out that findings from a million chest X-rays were utilized to develop the artificial intelligence (AI)-powered software, which was subsequently fine-tuned with over 50,000 labeled chest radiographs from radiologists.
"After over three years of research and collaboration with clinical teams, it's so exciting to see BraveCX emerge as a state-of-the-art tool that has actually 'listened to the end user,’” noted Ignat Drozdov, the CEO and founder of Bering. “FDA clearance means BraveCX prioritizes patient safety (while) still delivering the most advanced risk stratification algorithms where they are needed the most."
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.